Skip to Main Content

Author Details

Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
1993
202
55
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36599769Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.Clin Breast Cancer2023
37487147Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.JCO Precis Oncol2023
37643668Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.Crit Rev Oncol Hematol2023
37179432Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma.Sci Rep2023
36964667Treating secondary malignant neoplasms: A burden of childhood cancer survivors.Tumori2023
37262986Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.Eur J Cancer2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
34320204Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.J Natl Cancer Inst2022
35463374Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.Front Oncol2022
35356420The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to <i>BRCA1/2</i> Variant Type.Front Genet2022
35810556Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis.ESMO Open2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
34906479Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33573335Analysis of Italian <i>BRCA1/2</i> Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy.Cancers (Basel)2021
34761719Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families.Tumori2021
34573422Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.Genes (Basel)2021
34830781Fertility Counseling in Survivors of Cancer in Childhood and Adolescence: Time for a Reappraisal?Cancers (Basel)2021
34075482Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma.Int J Clin Oncol2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34100114Malignant salivary gland tumours in families with breast cancer susceptibility.Virchows Arch2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
32341527Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.Nat Genet2020
31723001Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness.Cancer Res2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33266155BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers.Cancers (Basel)2020
33322597A Mediterranean Dietary Intervention in Female Carriers of BRCA Mutations: Results from an Italian Prospective Randomized Controlled Trial.Cancers (Basel)2020
32899294Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma.Cancers (Basel)2020
32276467Analysis of <i>BRCA1</i> and <i>RAD51C</i> Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer.Cancers (Basel)2020
30613976Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.Int J Cancer2019
31209999The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.Hum Mutat2019
31264307Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?Psychooncology2019
31336362Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.Endocr Connect2019
30832263Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of <i>BRCA1/2</i> Variants of Uncertain Significance.Cancers (Basel)2019
30957000Co-occurrence of Mayer-Rokitansky-Küster-Hauser syndrome and ovarian cancer: A case report and review of the literature.Gynecol Oncol Rep2019
30634417Constitutive <i>BRCA1</i> Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer.Cancers (Basel)2019
30696104GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes.Cancers (Basel)2019
28681140Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations.Fam Cancer2018
30181513A Dietary Intervention to Lower Serum Levels of IGF-I in <i>BRCA</i> Mutation Carriers.Cancers (Basel)2018
29880896The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.Sci Rep2018
30204945BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.Hum Mutat2018
3025051113q mosaic deletion including <i>RB1</i> associated to mild phenotype and no cancer outcome - case report and review of the literature.Mol Cytogenet2018
30554731Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38-45].Cancer Genet2018
30564557Contribution of <i>MUTYH</i> Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy.Front Oncol2018
30410870Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.Front Oncol2018
29446198Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.Hum Mutat2018
29405995Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition.Cancer Genet2018
29460995The BRCA2 c.68-7T &gt; A variant is not pathogenic: A model for clinical calibration of spliceogenicity.Hum Mutat2018
29287190A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy.Breast2018
  • 1 - 50 of 202

Recommended Authors

Nicholas Pachter
King Edward Memorial Hospital
Career Start Year 2009
Number of shared co-authors 14
Sarah Thomas
Oncogenetics Team The Institute of Cancer Research London UK.
Career Start Year 2007
Number of shared co-authors 11
Sarah A Jackson
Robert H Lurie Comprehensive Cancer Center Northwestern University
Career Start Year 2007
Number of shared co-authors 5
Paz Polak
McGill University
Career Start Year 2006
Number of shared co-authors 7
Kasmintan A Schrader
University of British Columbia
Career Start Year 2005
Number of shared co-authors 41
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 35
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 21
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 8
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
Oleg Oszurek
Pomeranian Medical University
Career Start Year 2001
Number of shared co-authors 72
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 12
Edward D Esplin
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 12
Kathryn Alsop
Peter MacCallum Cancer Centre
Career Start Year 1998
Number of shared co-authors 62
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 16
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 85
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 25
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 5
Janine Senz
University of British Columbia
Career Start Year 1994
Number of shared co-authors 94
Simone Maistro
Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo
Career Start Year 1994
Number of shared co-authors 0
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Career Start Year 1993
Number of shared co-authors 2
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 35
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 5
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 17
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 52
Zsofia Kote-Jarai
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 120
Ming K Lee
University of Washington
Career Start Year 1988
Number of shared co-authors 9
Georgia L Wiesner
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 15
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 75
Sharon E Plon
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 27
Stephen N Thibodeau
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 118

Collaborators

Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 131
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 78
Fergus J Couch
Mayo Clinic
Co-authored papers 76
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 75
Douglas F Easton
University of Cambridge
Co-authored papers 75
Irene L Andrulis
University of Toronto
Co-authored papers 72
Jan Lubinski
Pomeranian Medical University
Co-authored papers 61
Esther M John
Co-authored papers 52
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 50
Susan M Domchek
Co-authored papers 45
David E Goldgar
University of Utah
Co-authored papers 44
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 44
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 43
Roger L Milne
Co-authored papers 43
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 43
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 42
Alison M Dunning
Co-authored papers 42
Graham G Giles
Co-authored papers 42
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 40
Per Hall
Co-authored papers 38
Diether Lambrechts
Co-authored papers 37
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 37
Hoda Anton-Culver
University of California irvine
Co-authored papers 36
Mary Beth Terry
Co-authored papers 36
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 35
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 33
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 33
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 32
Christopher A Haiman
University of Southern California
Co-authored papers 30
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 30
Release 1.2